Stem cell research took a few surprising twists during 2012, and California's $3 billion stem cell program completed its last building to support stem cell research. <\/p>\n
Here are some of the highlights for this year. <\/p>\n
-- People are composed of a genetic mosaic of cells, which slightly differ from each other. <\/p>\n
-- The 12th and last stem cell facility funded by the California Institute for Regenerative Medicine, in Santa Barbara, has opened. <\/p>\n
-- Geron's embryonic stem cell therapy for spinal cord damage, dropped in the middle of clinical trials, has been picked up by another biotech company, StemCells Inc. <\/p>\n
You can find out much more about each finding from the three stem cell blogs I got them from. They are: <\/p>\n
-- Knoepfler Lab Stem Cell Blog, run by prolific blogger and stem cell scientist Paul Knoepfler <\/p>\n
-- California Stem Cell Report, by veteran journalist David Jensen <\/p>\n
-- CIRM's official blog. <\/p>\n
But if you would rather read the gist of these findings here, read on. Plus, you'll get a video of one of the top scientists in the field giving his vision of where stem cell science should go. <\/p>\n<\/p>\n
Original post: <\/p>\n
The year (so far) in stem cells<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Stem cell research took a few surprising twists during 2012, and California's $3 billion stem cell program completed its last building to support stem cell research. Here are some of the highlights for this year Continue reading